Cheng-Yu Tsai

发表

Preclinical safety evaluation of calcineurin inhibitors delivered through an intraductal route to prevent post-ERCP pancreatitis demonstrates endocrine and systemic safety.

Cheng-Yu Tsai, R. Bottino, G. Papachristou, 2023, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].